A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT04830592 · COMPLETED
Trial details
- NCT number
- NCT04830592
- Sponsor
- Akamis Bio
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-04
- Primary completion
- 2023-12-07
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.